Mutations in SMCHD1 present with bosma arhinia microphthalmia syndrome (BAMS) or facioscapulohumeral muscular dystrophy type 2 (FSHD2), phenotypes not associated with RA or T1D39,40. This evidence concerns the gene SMCHD1 and rheumatoid arthritis.